GLPG2737

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)NCT04578548LKFTPhase 2Terminated2022-12-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.